CSL BEHRING L L C has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NANJING SAIERJIAN BIOTECHNOLOGY CO LTD, UNIV TECHNOLOGY CORP and BAXALTA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Separation | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Cook Paul I | 10 |
#2 | Fowler Scott A | 10 |
#3 | Smith James R | 10 |
#4 | Kling Robert | 10 |
#5 | Weber David | 10 |
#6 | Kee Scott M | 10 |
#7 | Yan Ming | 3 |
#8 | Lee Chi-Lin | 2 |
#9 | Bartlett Jeffrey | 2 |
#10 | Guan Chen Chao | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020139807A2 | Nanocapsules for the delivery of cell modulating agents | |
WO2020139796A1 | Haematopoietic stem cell-gene therapy for wiskott-aldrich syndrome | |
WO2020139800A1 | Donor t-cells with kill switch | |
AU2015200572A1 | Method for purification of alpha-1-antitrypsin | |
AU2012203030A1 | Method for purification of alpha-1-antitrypsin | |
US7777006B2 | Method for purification of alpha-1-antitrypsin |